WHO chooses M'sia to run trials on new drug to fight Covid-19


PETALING JAYA: Malaysia has been chosen by the World Health Organisation (WHO) as one of the countries to run trials on the effectiveness of a drug called Remdesevir to treat Covid-19 patients, says the National Security Council (NSC).

NSC said that Malaysia was chosen due to the ability of the Health ministry to undertake the research.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Cops bust drug syndicate in JB, seize RM200,000 of illegal substances
Body of missing police corporal found in Kampung Gajah canal
Engineer arrested for filing false robbery report in Rembau
Hotel bookings up across the board in Johor this week
MMEA performs emergency medical evacuation in Sandakan
Cultural run among draw at world tourism celebrations
Govts taking steps to protect kids in digital age
G25: More harm than good
Pensioners grateful for govt’s financial aid
Police looking into offensive notes on pizza receipts

Others Also Read